Olema Pharmaceuticals Inc (OLMA) Insider Trading
- $55,572,919.13
- $50,028,224.99
- March 4, 2026
- Cyrus Harmon
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 4, 2026 | Insider | 25,000 | $24.25 | Sell | $606,250.00 | |
| March 3, 2026 | Insider | 15,000 | $23.01 | Sell | $345,150.00 | |
| Sept. 18, 2025 | Director | 10,000 | $8.33 | Sell | $83,300.00 | |
| Sept. 16, 2025 | Director | 10,000 | $8.04 | Sell | $80,400.00 | |
| Jan. 8, 2025 | Major Shareholder | 300,000 | $5.76 | Buy | $1,728,000.00 | |
| Dec. 17, 2024 | Director | 700,761 | $6.75 | Sell | $4,730,136.75 | |
| Dec. 10, 2024 | Director | 8,256 | $9.37 | Sell | $77,358.72 | |
| Dec. 10, 2024 | Insider | 12,452 | $9.38 | Sell | $116,799.76 | |
| Dec. 10, 2024 | CEO | 52,328 | $9.37 | Sell | $490,313.36 | |
| Aug. 1, 2024 | Major Shareholder | 2,400,000 | $14.91 | Sell | $35,784,000.00 | |
| July 29, 2024 | Director | 4,066 | $15.58 | Sell | $63,348.28 | |
| July 11, 2024 | Director | 5,000 | $12.26 | Sell | $61,300.00 | |
| June 28, 2024 | Director | 20,000 | $10.77 | Sell | $215,400.00 | |
| June 3, 2024 | Director | 5,000 | $10.93 | Sell | $54,650.00 | |
| May 31, 2024 | Director | 15,000 | $9.41 | Sell | $141,150.00 | |
| May 6, 2024 | Director | 5,000 | $10.92 | Sell | $54,600.00 | |
| April 30, 2024 | Director | 15,000 | $9.51 | Sell | $142,650.00 | |
| March 28, 2024 | Director | 20,000 | $10.97 | Sell | $219,400.00 | |
| Feb. 29, 2024 | Director | 25,000 | $12.41 | Sell | $310,250.00 | |
| Jan. 31, 2024 | Director | 25,000 | $12.23 | Sell | $305,750.00 | |
| Dec. 6, 2023 | Major Shareholder | 100,000 | $11.60 | Buy | $1,160,000.00 | |
| Nov. 30, 2023 | Director | 25,000 | $12.57 | Sell | $314,250.00 | |
| Nov. 21, 2023 | Insider | 7,461 | $14.84 | Sell | $110,721.24 | |
| Nov. 21, 2023 | Director | 4,192 | $14.86 | Sell | $62,293.12 | |
| Nov. 21, 2023 | CEO | 29,293 | $14.88 | Sell | $435,879.84 | |
| Nov. 8, 2023 | Insider | 200 | $17.61 | Sell | $3,522.00 | |
| Nov. 3, 2023 | Insider | 541 | $17.51 | Sell | $9,472.91 | |
| Nov. 2, 2023 | Director | 5,000 | $15.64 | Sell | $78,200.00 | |
| Nov. 1, 2023 | Insider | 6,668 | $15.02 | Sell | $100,153.36 | |
| Oct. 31, 2023 | Director | 25,000 | $12.05 | Sell | $301,250.00 | |
| Sept. 29, 2023 | Director | 25,000 | $12.41 | Sell | $310,250.00 | |
| Sept. 19, 2023 | Insider | 20,000 | $12.67 | Sell | $253,400.00 | |
| Sept. 12, 2023 | Director | 1,505,932 | $9.84 | Buy | $14,818,370.88 | |
| Sept. 5, 2023 | Director | 10,000 | $11.62 | Sell | $116,200.00 | |
| Aug. 31, 2023 | Director | 15,000 | $9.36 | Sell | $140,400.00 | |
| June 8, 2023 | Director | 10,000 | $6.30 | Sell | $63,000.00 | |
| June 5, 2023 | Director | 5,000 | $6.04 | Sell | $30,200.00 | |
| June 10, 2022 | Director | 200,000 | $4.03 | Buy | $806,000.00 | |
| March 10, 2022 | Insider | 5,253 | $4.75 | Sell | $24,951.75 | |
| Jan. 10, 2022 | Insider | 5,251 | $6.85 | Sell | $35,969.35 | |
| Dec. 10, 2021 | Insider | 5,251 | $10.39 | Sell | $54,557.89 | |
| Nov. 30, 2021 | Director | 739,675 | $9.39 | Buy | $6,945,548.25 | |
| Nov. 29, 2021 | CTO | 400 | $24.76 | Sell | $9,904.00 | |
| Oct. 19, 2021 | CTO | 12,000 | $27.98 | Sell | $335,760.00 | |
| Oct. 14, 2021 | CEO | 5,000 | $30.47 | Sell | $152,350.00 | |
| Oct. 11, 2021 | Insider | 5,251 | $27.90 | Sell | $146,502.90 | |
| Sept. 27, 2021 | CEO | 1,085 | $30.07 | Sell | $32,625.95 | |
| Sept. 20, 2021 | CTO | 12,000 | $26.30 | Sell | $315,600.00 | |
| Sept. 10, 2021 | Insider | 5,251 | $29.38 | Sell | $154,274.38 | |
| Sept. 1, 2021 | CEO | 871 | $30.05 | Sell | $26,173.55 |
Insiders are both buying and selling Olema Pharmaceuticals Inc stock.
The insider traders at Olema Pharmaceuticals Inc are: Cyrus Harmon, Kinney Horn, David C Myles, Sean Bohen, Bvf Partners L P/Il, Shawnte Mitchell, Biocapital Advisors L Paradigm, G. Walmsley Graham, Naseem Zojwalla, Cormorant Asset Management, Lp, and Bain Capital Life Sciences Inv
The most active insider trader at Olema Pharmaceuticals Inc is Cyrus Harmon with 28 trades.
Biocapital Advisors L Paradigm has sold the most Olema Pharmaceuticals Inc stock with a total value of $71,568,000.00.
G. Walmsley Graham has bought the most Olema Pharmaceuticals Inc stock with a total value of $44,080,000.00.
The most recent insider trade for Olema Pharmaceuticals Inc was on March 4, 2026.
The single biggest insider buy for Olema Pharmaceuticals Inc was from G. Walmsley Graham with a total value of $22,040,000.00 on Nov. 23, 2020.
The single biggest insider sell for Olema Pharmaceuticals Inc was from Biocapital Advisors L Paradigm with a total value of $35,784,000.00 on Aug. 1, 2024.
